跳至主要内容
临床试验/NL-OMON26797
NL-OMON26797招募中不适用

Exhaled breath analysis for prediction of response to Mepolizumab in patients with severe asthma.

Amsterdam UMC, University of Amsterdam0 个研究点目标入组 250 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Adult patients with severe refractory eosinophilic asthma who are treated with Mepolizumab.
  • -Poor asthma control or frequent (≥2 per year) exacerbations, despite high-intensity treatment while alternative diagnoses have been excluded, comorbidities are treated and compliance has been checked.

排除标准

  • - Alcohol use <12 hours prior to measurement.
  • - Unwillingness or inability to comply with the study protocol for any other reason.

研究者

发起方
Amsterdam UMC, University of Amsterdam

相似试验

Analyse van uitgeademde lucht om de respons op... | 临床试验